Search results for PX-TA1409

Showing 1 – 10 of1products

ID: BAB182791742

Xentuzumab Biosimilar – Anti-IGF1, IGF2 mAb – Research Grade, ProteoGenix, PX-TA1409

Description of Xentuzumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade General information on Anti-IGF1/IGF2 [Homo sapiens] (Xentuzumab) Monoclonal Antibody Xentuzumab is investigated for the treatment of Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC).

Host

Reactivity

Applications

Conjugation

Compare

Request a product

Please provide the required information below so that we can quickly source your products.

Search results for PX-TA1409

Suppliers